Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF

The purpose of this study was to examine the association between the leucocyte nadir and prognosis in breast cancer patients receiving adjuvant chemotherapy consisting of cyclophosphamide, methotrexate and fluorouracil (CMF). Three hundred and sixty-eight patients with node-positive breast cancer wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Poikonen, P, Saarto, T, Lundin, J, Joensuu, H, Blomqvist, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363113/
https://www.ncbi.nlm.nih.gov/pubmed/10468293
http://dx.doi.org/10.1038/sj.bjc.6690594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363113/
https://www.ncbi.nlm.nih.gov/pubmed/10468293
http://dx.doi.org/10.1038/sj.bjc.6690594

Ejemplares similares